Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8088904 Tetrahydropyran nucleic acid analogs

Patent 8088904 was granted and assigned to Ionis Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Date Filed
August 15, 2008
0
Date of Patent
January 3, 2012
0
Patent Application Number
12192847
0
Patent Citations Received
‌
US Patent 12091662 Compositions for modulating tau expression
0
‌
US Patent 11713462 Modulation of GYS1 expression
0
‌
US Patent 11753644 Compounds and methods for reducing IFNAR1 expression
‌
US Patent 12129466 Compounds and methods for modulating UBE3A-ATS
0
‌
US Patent 11781135 Methods for treating Alzheimer's disease
‌
US Patent 11786546 Compounds and methods for modulating GFAP
‌
US Patent 11833168 Compounds and methods for increasing STMN2 expression
0
‌
US Patent 11834660 Compositions for modulating Ataxin 2 expression
0
‌
US Patent 11926825 Compounds and methods for reducing ATXN2 expression
0
‌
US Patent 11873495 Compounds and methods for reducing LRRK2 expression
0
•••
Patent Inventor Names
Thazha P. Prakash
0
Andrew M. Siwkowski
0
Balkrishen Bhat
0
Charles Allerson
0
Eric E. Swayze
0
Punit P. Seth
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8088904
0
Patent Primary Examiner
‌
Jezia Riley
0

Find more entities like US Patent 8088904 Tetrahydropyran nucleic acid analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.